Therefore, it has been proposed that CoQ0 inhibits hypoxia-induced ROS-mediated HIF-1α expression and thus attenuates the NLRP3-mediated inflammation, EMT/metastasis, and Warburg effect in HNSCC cells, which have been suggested as possible targets for cancer therapy. Here, NLRP3 is linked to head and neck squamous cell carcinoma.